Corvus Pharmaceuticals Inc (CRVS)

Corvus Pharmaceuticals Inc Azioni (CRVS) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	1.64% 5.651	5.56	5.622	6.574	5.666
Depreciation and Amortization	156.67% 0.077	0.03	0.036	0.057	-
Operating Income/Loss	1.64% -5.651	-5.56	-5.622	-6.574	-5.666
Income/Loss From Continuing Operations Before Tax	10.88% -6.653	-6.00	-6.503	-7.873	-9.816
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	10.88% -6.653	-6.00	-6.503	-7.873	-9.816
Net Income/Loss	10.88% -6.653	-6.00	-6.503	-7.873	-9.816
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.30% 0.3415	48.97	47.50	46.56	-
Diluted Average Shares	99.30% 0.3415	48.97	47.50	46.56	-
Basic Earnings Per Share	8.33% -0.13	-0.12	-0.14	-0.17	-0.21
Diluted Earnings Per Share	8.33% -0.13	-0.12	-0.14	-0.17	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-